Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 28Disease 3Obesity 2Carcinoma, Intraductal, Noninfiltrating 2Women With Breast Cancer 1Prostatic Neoplasms 1Obesity, Morbid 1Neoplasms 1Hypersensitivity 1Fibrocystic Breast Disease 1Digital Breast Tomosynthesis 1Cysts 1Colorectal Neoplasms 1Breast Screening 1Breast Cancer Screening 1Breast Cancer Detection 1Acquired Immunodeficiency Syndrome 1

Interventions

Tamoxifen 16Radiotherapy 9Anastrozole 8Letrozole 7Chemotherapy, Adjuvant 7Specimen Handling 6Radiation 5Neoadjuvant Therapy 5Mastectomy, Segmental 5Biopsy 5Sentinel Lymph Node Biopsy 4Psychiatric Rehabilitation 4Mass Spectrometry 4Immunohistochemistry 4Gene Expression Profiling 4Early Intervention, Educational 4Counseling 4exemestane 3afimoxifene 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Methods 3Mastectomy 3Magnetic Resonance Spectroscopy 3Fatty Acids, Omega-3 3Chromatography, High Pressure Liquid 3pasireotide 2Trastuzumab 2Standard of Care 2Soybean Proteins 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Intraductal, Noninfiltrating × Mammography × Clear all
NCT02492607 2026-01-26

LORD

The Netherlands Cancer Institute

Phase NA Active not recruiting
2,500 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT02909426 2021-10-07

MUST-BE

Soonchunhyang University Hospital

Unknown
11,880 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating, Hypersensitivity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡